Automated Text Messaging for Hypertension Gets High Ratings—and Shows why Randomized Controlled Trials are Important
Penn LDI
Digital clinical interactions, including telehealth appointments and online patient portals, are now common. Digital health platforms can’t be one-size-fits-all though, LDI Senior Fellow Eric Bressman says. Sustained, effective engagement will require dynamic strategies that adapt to patients’ responses, preferences, and needs.
A study led by Bressman found high engagement with a text-messaging platform for managing hypertension, but also demonstrated the importance of testing digital innovations in pragmatic, randomized controlled trials. Bressman answered questions about the work he did with LDI Senior Fellows Kevin Volpp and Anna Morgan, LDI Statistical Analyst Anthony Girard, and colleagues.
Read the Q&A on LDI’s website.